Finance

Lists
FLNA:BMV
Filana Therapeutics Inc
၁၅.၉၂ MX$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၅, GMT-၆ ၁၂:၀၅:၃၁  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for FLNA...
Mkt. cap
၃.၄၀ ကုဋေ
Avg. vol.
၀.၀၀
Volume
၀.၀၀
52-wk high
၅၆.၀၀ MX$
52-wk low
၁၅.၉၂ MX$
No. of employees
၁၉
Mkt. cap
၃.၄၀ ကုဋေ
Avg. vol.
၀.၀၀
Volume
၀.၀၀
52-wk high
၅၆.၀၀ MX$
52-wk low
၁၅.၉၂ MX$
No. of employees
၁၉
News stories
From web sources and news partners
AskTraders.com
AskTraders.com
·
ပြီးခဲ့သည့် ၁၇ မိနစ်
S&P 500 Can Absorb Fed Hikes, Says UBS CIO After Hot US Inflation
Benzinga
Benzinga
·
ပြီးခဲ့သည့် ၁ နာရီ
Dow Jones, Nasdaq 100, S&P 500 Outlook: Top Catalysts to Move US Stocks This Week
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ နာရီ
Did FDA Filings Just Shift Cogent Biosciences Stock Investment Narrative?
Profile
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. Currently led by President and CEO Richard Barry, Filana is working on developing simufilam to treat tuberous sclerosis complex–related epilepsy. The company previously was developing simufilam as an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials. In June 2024, the United States Department of Justice charged an advisor to Cassava Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. Wikipedia
About Filana Therapeutics Inc
CEO-
Employees၁၉
Founded၁၉၉၈
Headquartersအော်စတင်, တက္ကဆပ်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
၃.၉၆ သန်း
၃.၈၅ သန်း
၄.၅၄ သန်း
၃.၃၀ သန်း
Cost of revenue
၃.၉၆ သန်း
၃.၈၅ သန်း
၄.၅၄ သန်း
၃.၃၀ သန်း
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၇.၉၀ သန်း
၅.၇၀ သန်း
၆.၆၂ သန်း
၆.၀၉ သန်း
Operating expense
၇.၉၀ သန်း
၅.၇၀ သန်း
၆.၆၂ သန်း
၆.၀၉ သန်း
Total operating expenses
၁.၁၉ ကုဋေ
၉.၅၅ သန်း
၁.၁၂ ကုဋေ
၉.၃၉ သန်း
Operating income
-၁.၁၉ ကုဋေ
-၉.၅၅ သန်း
-၁.၁၂ ကုဋေ
-၉.၃၉ သန်း
Other non operating income
-၁.၁၄ သိန်း
၃.၉၀ သောင်း
၄.၈၀ သောင်း
၄.၃၀ သောင်း
EBT including unusual items
-၁.၀၈ ကုဋေ
-၁.၂၅ ကုဋေ
-၁.၀၃ ကုဋေ
-၈.၆၀ သန်း
EBT excluding unusual items
-၁.၀၈ ကုဋေ
-၈.၅၄ သန်း
-၁.၀၃ ကုဋေ
-၈.၆၀ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၀၈ ကုဋေ
-၁.၂၅ ကုဋေ
-၁.၀၃ ကုဋေ
-၈.၆၀ သန်း
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
၁.၁၇ သန်း
၉.၇၄ သိန်း
၇.၈၉ သိန်း
၇.၄၇ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၁၇ သန်း
၉.၇၄ သိန်း
၇.၈၉ သိန်း
၇.၄၇ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၁၇ ကုဋေ
-၉.၁၈ သန်း
-၁.၀၉ ကုဋေ
-၉.၁၅ သန်း
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ